MedTrace Logo

Antidepressant Decision Aid for Major Depressive Disorder Patients

NCT04761757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 752

Last updated 2021-02-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether Antidepressant Decision Aid for Major Depressive Disorder is feasible and effective in involving patients in the decision-making process when initiating pharmacotherapy.

Conditions

  • Depression
  • Depressive Symptoms
  • Depressive Disorder, Major
  • Mood Disorders

Interventions

OTHER

Booklet of Scripts of Doctors

The "Booklet of Scripts for Doctors" was used in the control arm. This tool was developed and tested to encourage shared decision-making in prescribing antidepressants within the Malaysian context.

OTHER

Booklet of Scripts for Doctors and the Antidepressant Decision Aid for Major depressive disorder patients (ADAM)

The "Booklet of Scripts for Doctors" along with the "Antidepressant Decision Aid for Major depressive disorder patients, ADAM", was used in the intervention arm. The decision aid was developed as per the International Patient Decision Aid Standards (IPDAS) criteria to enhance patient understanding of risks and benefits of different antidepressants available within the Malaysian context.

Sponsors & Collaborators

  • Ministry of Education, Malaysia

    collaborator OTHER_GOV

  • University of Malaya

    lead OTHER

Principal Investigators

  • Aya Ahmed Abousheishaa · University of Malaya

  • Ng Chong Guan · University of Malaya

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04761757 on ClinicalTrials.gov